![](https://innovativegenomics.org/wp-content/uploads/2024/07/WIES-Banner-2024-recolor2-1.jpg)
![Cartoon of a DNA strand](https://innovativegenomics.org/wp-content/uploads/2015/01/Screen-Shot-2015-01-29-at-4.03.00-PM-e1489628135198.png)
news
IGI and AstraZeneca to Collaborate on Genetic Role in Disease Pathology
The Innovative Genomics Initiative (IGI) today announced a new research collaboration with global biopharmaceutical company AstraZeneca using CRISPR genomic editing tools to address research applications across a broad range of therapeutic areas. IGI and AstraZeneca will be working closely together to identify and validate gene targets relevant to cancer; cardiovascular, metabolic, respiratory, autoimmune and inflammatory diseases; and regenerative medicine.
More information about this new collaboration will be available at the IGI Grand Opening Celebration on Feb 4, 2015.